↓ Skip to main content

Severe Disease Activity and Cytomegalovirus Colitis Are Predictive of a Nonresponse to Infliximab in Patients with Ulcerative Colitis

Overview of attention for article published in Digestive Diseases and Sciences, August 2013
Altmetric Badge

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
52 Mendeley
Title
Severe Disease Activity and Cytomegalovirus Colitis Are Predictive of a Nonresponse to Infliximab in Patients with Ulcerative Colitis
Published in
Digestive Diseases and Sciences, August 2013
DOI 10.1007/s10620-013-2828-1
Pubmed ID
Authors

Sang Hyoung Park, Suk-Kyun Yang, Seung-Mo Hong, Soo-Kyung Park, Jong Wook Kim, Hyo Jeong Lee, Dong-Hoon Yang, Kee Wook Jung, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jin-Ho Kim

Abstract

The role of infliximab in the treatment of patients with ulcerative colitis (UC) in Asia is still unclear. The aim of this study was to evaluate the clinical outcomes of infliximab therapy in Korean UC patients, including efficacy and predictors of response.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 17%
Student > Master 8 15%
Other 4 8%
Student > Ph. D. Student 3 6%
Professor 3 6%
Other 13 25%
Unknown 12 23%
Readers by discipline Count As %
Medicine and Dentistry 28 54%
Computer Science 4 8%
Nursing and Health Professions 2 4%
Agricultural and Biological Sciences 1 2%
Immunology and Microbiology 1 2%
Other 3 6%
Unknown 13 25%